Semaglutide: side effects, cost, and tirzepatide compared
Semaglutide is the GLP-1 medication inside Wegovy and Ozempic. Here’s what side effects to expect, what it costs, and how it compares with tirzepatide. When you’re ready, a licensed Roen provider can evaluate you online.
- A once-weekly GLP-1 injection, first FDA-approved in 2017
- Brand-name semaglutide as low as $25/mo when your insurance covers it*
- Compounded semaglutide for $199/mo, or $106/mo on a 3-month supply
- No appointment required. Your provider reviews everything by message
See important safety information for semaglutide, including a boxed warning.
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist made by Novo Nordisk. It copies a hormone your gut releases after you eat. The result is that you feel full sooner, food leaves your stomach more slowly, and your body handles blood sugar better.
The injectable form is sold as Ozempic, approved in 2017 for type 2 diabetes, and Wegovy, approved in 2021 for chronic weight management.2,3 There is no FDA-approved generic of either one.
Wegovy, Ozempic, or compounded: what’s the difference?
The active ingredient is the same in all three. The approved use, the dose, and the price are not.
Wegovy
- FDA-approved for weight management, and for cardiovascular risk reduction in certain adults.
- Maintenance dose of 2.4 mg a week.
Ozempic
- FDA-approved for type 2 diabetes.
- Doses up to 2 mg a week. Usually covered only with a diabetes diagnosis.
Compounded semaglutide
- Made by a compounding pharmacy to fill an individual prescription.
- Not FDA-approved. The FDA has not reviewed it for safety, effectiveness, or quality.
- Something a Roen provider may prescribe when insurance won’t cover a brand.
Semaglutide vs tirzepatide: what’s the difference?
Both are weekly injections that curb appetite. Semaglutide works on one hormone pathway, GLP-1. Tirzepatide, the ingredient in Zepbound and Mounjaro, works on GLP-1 and a second one, GIP.
- Weight loss: in a head-to-head trial, the average was 13.7% on semaglutide and 20.2% on tirzepatide.9
- Track record: semaglutide has been on the market since 2017, tirzepatide since 2022.
- Price through Roen: compounded semaglutide is $199/mo, or $106/mo on a 3-month supply. Compounded tirzepatide is $329/mo, or $216/mo on a quarterly plan.
See the full semaglutide vs tirzepatide comparison.
*Requires commercial insurance that covers the prescribed brand and enrollment in Novo Nordisk’s savings offer for that brand. Savings are capped and government-insured patients are not eligible. See cost details. †$106/mo applies to a 3-month supply; $199/mo billed monthly. Compounded medications are not FDA-approved. Roen membership ($39 first month, then $135/mo) is separate from medication.
Safety summary: Semaglutide can cause serious side effects, including possible thyroid tumors. Do not use it if you or a family member has had medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Read more safety information.
Two years in, adults on semaglutide had kept off about 15% of their weight
The STEP 5 trial followed adults with obesity or overweight for 104 weeks. Those on semaglutide 2.4 mg had lost an average of 15.2% of their starting weight, compared with 2.6% on placebo.1 That lines up with the 14.9% average seen at 68 weeks in the first major trial.7
at the 15.2% average 38lbs
Placebo group in the same trial: about 7 lbs
An illustration based on trial averages for FDA-approved semaglutide 2.4 mg, not a prediction. Participants also received lifestyle counseling. Compounded semaglutide was not studied in these trials.
The two brand names for injectable semaglutide
Wegovy and Ozempic are the same medication made for different purposes. Which one a plan covers depends on your diagnosis.
| Wegovy®For weight management | Ozempic®For type 2 diabetes | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| FDA-approved for | Chronic weight management, and reducing cardiovascular risk in adults with heart disease and obesity or overweight | Type 2 diabetes, including cardiovascular and kidney risk reduction in certain adults |
| Weekly dose range | 0.25 mg to 2.4 mg | 0.25 mg to 2 mg |
| Insurance usually covers it when | Your plan includes weight-management drugs and you meet its criteria | You have a type 2 diabetes diagnosis |
| Novo Nordisk savings offer | As low as $25/mo with covered commercial insurance | As low as $25 for up to a 3-month prescription with covered commercial insurance |
| Self-pay through NovoCare | $199/mo for the first two months, then $349/mo | $199/mo for the first two months, then $349/mo ($499/mo for 2 mg) |
| If neither is covered | A Roen provider can prescribe compounded semaglutide when appropriate: $199/mo, or $106/mo on a 3-month supply. | |
How to get semaglutide through Roen
Brand-name or compounded, the path is the same and none of it requires leaving home.
1. Create your account
Sign up for $39 and complete a short health intake covering your medical history, medications, and goals. Have a rough idea of your current weight and any recent lab work.
2. A licensed provider reviews your intake
A Roen clinician checks whether semaglutide is appropriate and safe for you. Because the review is done by message, you don’t need to book or wait for an appointment. They’ll reach out if anything is unclear.
3. We check your coverage
Upload your insurance card and we’ll see whether your plan covers Wegovy or Ozempic. When it does, Novo Nordisk’s savings offer can lower the brand-name price to as little as $25.
4. Your medication is dispensed
Covered: your Wegovy or Ozempic prescription is filled through a partner pharmacy. Not covered: your provider can prescribe compounded semaglutide, shipped to your door for $199 a month, or $106 a month on a 3-month supply.
5. Adjust as you go
Semaglutide starts at a low dose and increases about once a month. Message your care team when you have questions or side effects. Your provider decides when to move up and when to wait.

What membership includes, whichever semaglutide you take
- A licensed provider’s evaluation, and a prescription when appropriate
- Coverage checks for Wegovy and Ozempic
- Care by message, with visits available at no extra charge
- A dosing plan your provider adjusts over time
- Support when side effects come up
- Access to Wegovy, Ozempic, and compounded semaglutide
Medication is not included in the membership price and is billed separately.
Get StartedSemaglutide side effects: what’s common and what’s serious
The most common semaglutide side effects are nausea, diarrhea, vomiting, constipation, and stomach pain. They’re more frequent at higher doses, which is why rates in the Wegovy trials are higher than in the Ozempic trials.
| Common side effect | Wegovy trials (2.4 mg) | Ozempic trials (0.5–1 mg) |
|---|---|---|
| Nausea | 44% | 16–20% |
| Diarrhea | 30% | 9% |
| Vomiting | 24% | 5–9% |
| Constipation | 24% | 3–5% |
| Stomach (abdominal) pain | 20% | 6–7% |
Approximate share of adults reporting each effect on semaglutide in placebo-controlled trials.2,3 At the 2.4 mg dose, headache (14%), fatigue (11%), indigestion (9%), and dizziness (8%) were also common. These figures come from studies of the FDA-approved products.
How long do semaglutide side effects last?
They tend to cluster around dose increases. In Ozempic’s trials, most reports of nausea, vomiting, and diarrhea came while the dose was still going up.3 In Wegovy’s weight-management trials, 6.8% of adults stopped treatment because of side effects, compared with 3.2% on placebo.2
Other semaglutide side effects
Hair loss was reported by 3% of adults on Wegovy and 1% on placebo.2 The hollowed look nicknamed “Ozempic face” comes from losing weight quickly rather than from semaglutide itself. We cover it on our Ozempic page.
Getting through the first few months
- Smaller, slower meals help more than anything else.
- Avoid rich or greasy food for a day or two after your injection.
- Drink plenty of fluids, especially if you’ve been sick.
- Fiber and water can help with constipation. Ask your provider before adding a laxative.
- Tell your provider if symptoms don’t settle. Spending longer at a lower dose is a common adjustment.
Serious side effects: get help right away
- Pancreatitis: severe stomach pain that won’t go away, with or without vomiting, sometimes felt through to your back.
- Gallbladder problems: upper-stomach pain, fever, yellowing of the skin or eyes, clay-colored stools.
- Low blood sugar, mostly in people with type 2 diabetes who also take insulin or a sulfonylurea.
- Kidney problems from dehydration after vomiting or diarrhea.
- Serious allergic reaction: swelling of the face, lips, tongue, or throat; trouble breathing; severe rash or itching; fainting.
- Vision changes in people with type 2 diabetes.
- A lump or swelling in your neck, hoarseness, or trouble swallowing. See the boxed warning.
How semaglutide dosing builds up
For weight management, semaglutide follows the Wegovy schedule shown here: four weeks at each dose, reaching 2.4 mg in the fifth month. For type 2 diabetes, Ozempic starts the same way and tops out at 2 mg. Either way, your provider can slow things down if side effects get in the way.
- 0.25 mgWeeks 1–4
Starting dose - 0.5 mgWeeks 5–8
- 1 mgWeeks 9–12
- 1.7 mgWeeks 13–16
Maintenance option - 2.4 mgWeek 17 onward
Maintenance dose
If you’re prescribed compounded semaglutide, follow the dosing instructions from your provider and pharmacy exactly, and ask if anything about measuring your dose is unclear. More in our guides to semaglutide side effects, GLP-1 side effects as a class, the semaglutide dosing schedule, and Ozempic dosage.
Semaglutide vs tirzepatide: which one fits you?
Semaglutide and tirzepatide are the two best-known weight loss injections, and they’re close relatives. The differences come down to how much weight people lose on average, what each is approved for, and what you’ll pay.
How do semaglutide and tirzepatide differ?
Semaglutide mimics one gut hormone, GLP-1. Tirzepatide mimics GLP-1 and a second hormone, GIP. Both are injected once a week, both slow how quickly your stomach empties and turn down appetite, and both start at a low dose that rises over several months.
Which leads to more weight loss?
Tirzepatide, on average. In the 72-week SURMOUNT-5 trial of adults with obesity, people on semaglutide lost 13.7% of their body weight and people on tirzepatide lost 20.2%.9 The study was funded by tirzepatide’s maker, Eli Lilly. Averages hide a wide spread, and many people reach their goals on semaglutide.
Where semaglutide has the edge
Semaglutide has been prescribed since 2017, so it has the longer track record. Wegovy is approved to lower the risk of heart attack and stroke in adults with heart disease and obesity or overweight.2 It’s the only one of the two that comes as a pill. And through Roen, compounded semaglutide costs less than compounded tirzepatide.
Are the side effects different?
Not in kind. Both mainly cause nausea, diarrhea, vomiting, and constipation. In their separate weight-management trials, nausea was reported by 44% of adults on Wegovy and 25% to 29% on Zepbound, though different trials can’t be compared precisely.2,10 Our tirzepatide page has its full side effect table.
| SemaglutideWegovy®, Ozempic® | TirzepatideZepbound®, Mounjaro® | |
|---|---|---|
| Drug class | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| First FDA approval | 2017, as Ozempic | 2022, as Mounjaro |
| Brand for weight management | Wegovy, approved 2021 | Zepbound, approved 2023 |
| Average weight loss, head-to-head | 13.7% at 72 weeks | 20.2% at 72 weeks |
| Usual maintenance dose for weight | 2.4 mg a week | 5 mg, 10 mg, or 15 mg a week |
| Also approved for | Cardiovascular risk reduction. Type 2 diabetes | Obstructive sleep apnea. Type 2 diabetes |
| Available as a pill | Yes, the Wegovy pill | No. Injection only |
| Compounded, through Roen | $199/mo, or $106/mo on a 3-month supply | $329/mo, or $216/mo on a quarterly plan |
| Brand-name, insurance covers it | As low as $25/mo for either, with the manufacturer’s savings offer. | |
Head-to-head figures are from SURMOUNT-5.9 Approvals are for the brand-name products. Compounded medications are not FDA-approved. Your provider can tell you which medication suits your health history.
Semaglutide cost: brand, self-pay, and compounded prices
The price of semaglutide varies more by route than by dose. These are the main ways people pay for it.
| Your situation | What you may pay | The fine print |
|---|---|---|
| Wegovy, with commercial insurance that covers it | As little as $25 a month | Novo Nordisk’s savings offer takes off up to $100 a month.4 |
| Ozempic, with commercial insurance that covers it | As little as $25 for up to a 3-month prescription | Savings are capped at $100 a month. Plans generally cover Ozempic for type 2 diabetes.5 |
| Brand-name, paying cash | Wegovy or Ozempic pen: $199 a month for the first two months on starter doses, then $349 a month | Sold through NovoCare. The intro price is for new patients through December 31, 2026. Ozempic 2 mg is $499 a month. The Wegovy pill runs $149 to $299 a month by dose.6 |
| Compounded semaglutide through Roen | $199 a month, or $106 a month on a 3-month supply | Prescribed when a Roen provider finds it appropriate and shipped from a partner pharmacy. Not FDA-approved. |
| Medicare, Medicaid, TRICARE, VA, or other government coverage | Novo Nordisk savings offers not available | Most Medicare Part D plans cover Ozempic for type 2 diabetes. For Wegovy, the Medicare GLP-1 Bridge offers eligible Part D patients a $50 monthly price from July 1, 2026 through December 31, 2027, with prior authorization. |
Manufacturer prices and offer terms are set by Novo Nordisk and can change or end at any time. Roen prices exclude membership.
Is there a semaglutide coupon?
- Not for “semaglutide” in general. Wegovy and Ozempic each have their own savings offer from Novo Nordisk.
- The $25 prices require commercial insurance that covers the brand you’re prescribed.
- Government-insured patients can’t use either offer.
- Manufacturer offers don’t apply to compounded semaglutide, and coupon-site codes don’t stack with them. See what a GoodRx Wegovy coupon actually gets you.
What you pay with Roen
- Membership: $39 for the first month, then $135/mo.
- Wegovy or Ozempic, insurance covers it: as low as $25/mo for the medication.
- Insurance doesn’t cover it: compounded semaglutide at $199/mo, or $106/mo on a 3-month supply.
Medication is billed separately from membership. Compounded medications are not FDA-approved.
What to know about compounded semaglutide before you start
Compounded semaglutide is prepared by a licensed pharmacy for a specific patient’s prescription. It isn’t Wegovy or Ozempic, it isn’t a generic, and it isn’t FDA-approved.
The FDA has raised two concerns specific to compounded semaglutide: dosing mistakes when people measure their own doses from a vial, and products made with semaglutide salts, which are not the same active ingredient as the approved drugs.8
Through Roen, a licensed provider decides whether compounded semaglutide is appropriate for you. It ships to all 50 states, and you can message your care team with any question about measuring a dose. Our compounded semaglutide safety guide goes deeper.

| Brand-nameWegovy® or Ozempic® | Compounded semaglutide | |
|---|---|---|
| Made by | Novo Nordisk | A compounding pharmacy, for an individual prescription |
| FDA-approved | Yes | No. Not reviewed by the FDA for safety, effectiveness, or quality |
| Doses | Fixed-dose pens | Set by your provider on your prescription |
| Insurance | May be covered, depending on your plan and diagnosis | Generally not covered by insurance |
| Medication cost through Roen | As low as $25/mo with covered insurance and Novo Nordisk’s savings offer | $199/mo, or $106/mo on a 3-month supply |
| How you get it | Filled through a partner pharmacy | Shipped to your door from a partner pharmacy |
| Where it’s available | All 50 states | All 50 states |
Trial results and side-effect rates on this page come from studies of FDA-approved semaglutide. Roen is not affiliated with Novo Nordisk.

Curious how semaglutide stacks up?
- Your provider can compare semaglutide and tirzepatide with you
- Brand-name and compounded routes, with coverage or without
- The same membership no matter which medication you’re prescribed
Compare your options:
Members on their Roen experience
Individual experiences vary.
I was curious about semaglutide but wanted to understand my options before deciding. My provider reviewed my health history and gave me space to ask questions. I appreciated having a conversation that felt focused on me and what I needed to know.
My biggest question about semaglutide was what ongoing care would look like. We discussed follow-up check-ins, potential side effects, and when to contact the care team. Having those details explained helped me feel more prepared for the next step.
I sent my provider a whole list of questions about semaglutide. They patiently worked through them with me, including how treatment might fit into my broader health plan. I left feeling heard and better informed about my choices.

A licensed provider decides if semaglutide is right for you
Nothing is prescribed until a clinician has read your health history. They’ll tell you whether semaglutide makes sense, which version fits, and what to consider if it doesn’t.
Semaglutide FAQs
What are the most common semaglutide side effects?
The most common semaglutide side effects are nausea, diarrhea, vomiting, constipation, and stomach pain. They’re more frequent at higher doses: 44% of adults on semaglutide 2.4 mg reported nausea, compared with 16% to 20% at the 0.5 mg and 1 mg doses.
Serious side effects are much rarer and include pancreatitis, gallbladder problems, kidney problems from dehydration, and serious allergic reactions. Semaglutide carries a boxed warning about thyroid C-cell tumors. See the full side effect table.
Semaglutide vs tirzepatide: what’s the difference?
Semaglutide (Wegovy, Ozempic) acts on one hormone receptor, GLP-1. Tirzepatide (Zepbound, Mounjaro) acts on two, GIP and GLP-1. Both are weekly injections with similar digestive side effects.
In a 72-week head-to-head trial, average weight loss was 13.7% on semaglutide and 20.2% on tirzepatide. Semaglutide has the longer track record, an approved cardiovascular benefit, a pill form, and a lower compounded price through Roen. See semaglutide vs tirzepatide.
How much does semaglutide cost?
Brand-name Wegovy or Ozempic can cost as little as $25 with commercial insurance that covers it and Novo Nordisk’s savings offer. Paying cash through NovoCare, the pens are $199 a month for the first two months on starter doses for new patients, then $349 a month for most doses, as of November 2026. Compounded semaglutide through Roen is $199 a month, or $106 a month on a 3-month supply.
Roen membership is billed separately: $39 for the first month, then $135 a month. See the full cost breakdown.
How long do semaglutide side effects last?
They tend to be strongest in the days after a dose increase and ease over the following weeks. Since the dose goes up roughly once a month at first, symptoms can come and go for the first few months. If they’re severe or don’t improve, your provider can hold your dose or reduce it.
What is compounded semaglutide?
It’s semaglutide prepared by a compounding pharmacy for an individual prescription. It is not FDA-approved, so the FDA has not reviewed it for safety, effectiveness, or quality, and it is not a generic of Wegovy or Ozempic. A Roen provider may prescribe it when it’s appropriate for you. Read what to know before you start.
Is tirzepatide more effective than semaglutide?
For weight loss, tirzepatide produced a larger average result in the one large head-to-head trial: 20.2% versus 13.7% over 72 weeks. That’s an average, and it isn’t the whole picture. Semaglutide is approved to reduce cardiovascular risk in certain adults, and what your insurance covers and how you tolerate each medication matter just as much. Your provider can compare it with tirzepatide for you.
Can you switch between semaglutide and tirzepatide?
Yes, if your provider recommends it. People switch because of side effects, a plateau, cost, or a change in insurance coverage. There’s no official dose conversion between the two, so your provider decides where to start the new medication and how to time the change. Don’t take both at once.
Is there a semaglutide pill?
Yes. The Wegovy pill is a once-daily semaglutide tablet that the FDA approved for weight management in December 2025. Rybelsus is an older semaglutide tablet approved for type 2 diabetes. See our Wegovy pill guide for how the pill compares with the injection.
Is semaglutide the same as Ozempic and Wegovy?
Semaglutide is the active ingredient in both. Ozempic is approved for type 2 diabetes at doses up to 2 mg a week. Wegovy is approved for weight management with a 2.4 mg maintenance dose. Both are made by Novo Nordisk, and insurance treats them as separate drugs.
How much weight can you lose on semaglutide?
In trials of semaglutide 2.4 mg in adults without diabetes, average weight loss was 14.9% at 68 weeks and 15.2% at two years, compared with about 2.5% on placebo. People with type 2 diabetes tend to lose somewhat less. These trials studied FDA-approved semaglutide alongside lifestyle changes, and individual results vary.
Is there a generic semaglutide?
There is no FDA-approved generic of Wegovy or Ozempic in the United States. Compounded semaglutide is a different category of medication and is not FDA-approved.
How do you take semaglutide?
Injectable semaglutide is taken once a week, on the same day each week, under the skin of your abdomen, thigh, or upper arm. It can be taken with or without food. Doses start at 0.25 mg and increase about every four weeks under your provider’s direction.
Do I need a video visit to get semaglutide through Roen?
No. With a Roen membership, a licensed provider can evaluate you and prescribe asynchronously, without a scheduled appointment. Visits are included in your membership if you want one.
What does the Roen membership include?
Membership is $39 for the first month, then $135 a month. It covers your provider evaluation, visits, insurance coverage checks for Wegovy and Ozempic, and ongoing support with dosing and side effects. Medication is billed separately.
Which states does Roen serve for semaglutide?
Roen serves all 50 states. That covers brand-name Wegovy and Ozempic as well as compounded semaglutide.
Read more about semaglutide
Important safety information
What you should know before taking semaglutide. This applies to Wegovy and Ozempic. Assume the same warnings apply to compounded semaglutide, which has not been evaluated by the FDA.
Boxed warning: risk of thyroid C-cell tumors
Semaglutide caused thyroid tumors, including thyroid cancer, in studies with rodents. It isn’t known whether semaglutide causes thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Don’t use semaglutide if you or a family member has ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about any lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
Who should not take semaglutide
- Anyone with a personal or family history of MTC, or with MEN 2.
- Anyone who has had a serious allergic reaction to semaglutide or any ingredient in the product.
Before you start, tell your provider if you
- Have or have had problems with your pancreas or kidneys.
- Have type 2 diabetes, a history of diabetic retinopathy, or take insulin or a sulfonylurea.
- Have or have had depression, suicidal thoughts, or other mental health concerns.
- Are scheduled for surgery or a procedure that uses anesthesia or deep sedation.
- Are pregnant or planning to become pregnant. Stop semaglutide at least 2 months before you plan to become pregnant.
- Are breastfeeding or plan to breastfeed.
- Use another semaglutide product or another GLP-1 medicine. They should not be combined.
Possible serious side effects
- Inflammation of the pancreas (pancreatitis).
- Gallbladder problems, including gallstones.
- Low blood sugar, especially with insulin or a sulfonylurea.
- Kidney problems, including kidney failure, often related to dehydration.
- Severe stomach problems.
- Serious allergic reactions.
- Changes in vision in people with type 2 diabetes.
- Increased heart rate.
- Depression or thoughts of suicide.
- Food or liquid getting into the lungs during surgery or procedures that use anesthesia.
Most common side effects
Nausea, diarrhea, vomiting, constipation, stomach pain, headache, tiredness, upset stomach, dizziness, bloating, belching, gas, and heartburn.
This summary doesn’t include everything about semaglutide and doesn’t replace a conversation with your provider. Read the full Prescribing Information and Medication Guide for Wegovy or Ozempic. To report side effects, contact the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
- Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28:2083–2091.
- Wegovy (semaglutide) Prescribing Information. Novo Nordisk. novo-pi.com
- Ozempic (semaglutide) Prescribing Information. Novo Nordisk. novo-pi.com
- Wegovy coverage and savings. Novo Nordisk. wegovy.com
- Ozempic savings and resources. Novo Nordisk. ozempic.com
- NovoCare home delivery. Novo Nordisk. novocare.com/pharmacy
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989–1002.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. fda.gov
- Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393:26–36.
- Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. pi.lilly.com
Page last updated November 17, 2026.
See which form of semaglutide fits you
Share your health history and a licensed provider will review your options. Membership is $39 for the first month.
Get StartedZepbound®, Mounjaro®, KwikPen®, and LillyDirect® are registered trademarks of Eli Lilly and Company. Ozempic®, Wegovy®, and NovoCare® are registered trademarks of Novo Nordisk A/S. Roen is not affiliated with or endorsed by these companies. Prescriptions are issued only after a licensed provider determines that treatment is appropriate. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. This page is for general information and is not medical advice.



